![Steve O'Loughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steve O'Loughlin
Director of Finance/CFO at
CNS PHARMACEUTICALS, INC.
Net worth: 990 $ as of 2026-07-30
Profile
Mr. Steve O'Loughlin is a Chief Financial Officer at CNS Pharmaceuticals, Inc. Mr. O'Loughlin was previously employed as a Chief Financial & Accounting Officer by Actinium Pharmaceuticals, Inc. and a Vice President-Corporate Finance & Development by Protea Biosciences Group, Inc. He received his undergraduate degree from Ramapo College of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-10-14 | 1,183 ( 0% ) | 990 $ | 2026-07-30 |
Steve O'Loughlin active positions
| Companies | Position | Start |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2026-03-01 |
Former positions of Steve O'Loughlin
| Companies | Position | End |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2026-02-26 |
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 2015-05-31 |
Training of Steve O'Loughlin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Ramapo College of New Jersey
 Ramapo College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides innovative bioanalytical solutions | Commercial Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
- Stock Market
- Insiders
- Steve O'Loughlin
